Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methothrexate, and daily prednisone (DalCMP) as therapy for metastatic breast cancer (MBC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sousa, BA
  • Buckman, RA
  • Clemons, M
  • Dent, SF
  • Wong, NS
  • Kerbel, R
  • Sutherland, DJ
  • Emmenegger, U
  • Gardner, S
  • Pritchard, Kathleen

publication date

  • May 20, 2010